Delivery Order SPE2DB20D3303-SPE2DB25FZ7K3
- Not listed
- The Defense Logistics Agency awarded a $2,515.44 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam (10 grams) with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued on September 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,341.66 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% foam in a 10-gram formulation. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,276.46 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a completion date of July 25, 2025. The delivery order was issued on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,620 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units, with an ultimate completion date of September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for PROCTOFOAM-HC 1%-1% Foam in a 10-gram unit with a ceiling value of $1,221.66. This is a non-set-aside competitive award with an ultimate completion date of April 25, 2025. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,131.59 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on May 21, 2025, with an ultimate completion date of May 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,231.42 to provide PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract has a completion date of February 22, 2024 and was awarded on February 21, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on...
- The Defense Logistics Agency awarded a $2,936.60 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam in 10-gram units, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct procurement through the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,724.56 on September 3, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,096.00 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FZ7K3Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio focused on military and veteran healthcare supply chains. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical commodities to support Defense Health Agency and military healthcare programs worldwide. This particular delivery order represents one of numerous small-value transactions processed under the broader pharmaceutical prime vendor contract, demonstrating the company's capability to fulfill diverse federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/6/25 |